查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1948160

2034年全球类器官与球状体市场机会与策略

Organoids And Spheroids Global Market Opportunities And Strategies To 2034
出版日期: | 出版商: The Business Research Company | 英文 355 Pages | 商品交期: 2-10个工作天内

价格
简介目录

全球类器官和球状体市场预计到2024年将达到约11.5946亿美元，自2019年以来年复合成长率为20.38%。预计该市场将从2024年的11.5946亿美元成长到2029年的28.672亿美元，年复合成长率为19.85%。之后，预计从2029年起将继续以19.34%的年复合成长率成长，到2034年达到69.3947亿美元。

类器官和球状体是三维（3D）细胞培养模型，旨在体外忠实重现人体组织和器官的结构、功能和微环境。球状体是简单的球形细胞丛集，能够自组织复製基本的组织结构；而类器官则是更为复杂的干细胞衍生三维结构，能够模拟特定的器官功能和细胞多样性。这些模型来自干细胞、原代组织或癌细胞，并在受控环境下培养时自组织成复杂的类组织结构。

对个人化和精准医疗的需求日益增长

过去，对个人化和精准医疗日益增长的需求推动了类器官和球状体市场的发展。这些3D细胞培养模型能够忠实地复製人体组织的结构和功能，从而实现更精确的疾病建模、药物筛检和针对个别患者的治疗方法测试。製药和生物技术公司正越来越多地采用类器官和球状体来开发标靶治疗、降低临床试验失败率并加速研发进程。随着人们越来越关注患者特异性治疗方法和客製化医疗解决方案，这些先进模型的应用已成为精准医疗领域不可或缺的工具，并促进了市场的强劲成长。例如，根据美国非营利组织个人化医疗联盟（Personalized Medicine Coalition）的数据显示，截至2024年2月，美国食品药物管理局（FDA）在2023年核准了16种用于治疗罕见疾病的个人化治疗方法，高于2022年的6核准。因此，对个人化和精准医疗日益增长的需求推动了类器官和球状体市场的成长。

创新的渗透性培养技术提高了3D细胞生长和体外建模效率

在类器官和球状体市场中，主要企业正致力于开发先进的培养平台和材料，以增强细胞活力和氧气输送，从而提高药物研发、再生医学和个人化治疗等应用领域体外模型的准确性和扩充性。例如，2025年6月，日本化学品製造商三井化学集团推出了渗透性细胞培养微孔盘「InnoCell」。这款创新微孔盘结合了该公司特有的材料和精密切割技术，能够增强细胞氧气输送，减少细胞死亡，并提高细胞长期存活率，尤其是在3D球状体和类器官培养中。本产品有两种类型：未处理型（N型）和胶原蛋白包被型（C型），以适应多种细胞类型。此外，它还具有低药物吸附和优异的萤光成像性能。这些优势使该产品能够为药物研发、个人化医疗、再生医学和药物研究中的先进体外建模提供支援。

全球类器官和球状体市场是一个相对集中的市场，主要由大型企业参与。截至2024年，排名前十的主要企业将占据31.03%的市场。

目录

第一章执行摘要

第二章 目录

第三章表格一览

第四章图表一览

第五章 报告结构

第六章 市场特征

  • 一般市场定义
  • 概述
  • 类器官和球状体市场定义和细分
  • 按类型分類的市场细分
    • 类器官
    • 球状体
  • 依方法进行市场区隔
    • 细胞外基质支架
    • 旋转生物反应器法
    • 悬滴法
    • 低黏附性培养板法
    • 磁浮
    • 其他方法
  • 市场区隔：按应用
    • 发育生物学
    • 个人化医疗
    • 再生医学
    • 疾病病理学研究
    • 药物毒性和疗效测试
  • 市场区隔：依最终用户划分
    • 生物技术和製药业
    • 学术研究机构
    • 医院和诊断中心

第七章：主要市场趋势

  • 创新的渗透性培养技术提高了3D细胞生长和体外建模效率
  • 血管化类器官工程为再生医学和疾病建模开闢了新途径
  • 可扩展功能性肝臟类器官的突破性进展推动了再生医学和药物测试应用的发展。
  • 人工智慧整合的心臟类器官创新提升药物安全性和精准医疗
  • 整合式3D细胞培养技术加速了再生医学和生物製药研究的进展

8. 类器官和球状体的生长分析和策略分析框架

  • 全球类器官和球状体市场的PESTEL分析（政治、社会、技术、环境、法律因素、驱动因素和限制因素）
    • 政治因素
    • 经济
    • 社会的
    • 技术的
    • 环境
    • 合法的
  • 终端用户（B2B）市场分析
    • 生物技术和製药业
    • 学术研究机构
    • 医院和诊断中心
  • 类器官和球状体市场：成长率分析
  • 2019-2024年全球市场成长表现
    • 2019-2024年市场驱动因素
    • 2019-2024年市场限制
  • 全球市场成长预测，2024-2029年，2034年预测
  • 预期成长要素/驱动因素
    • 定量成长要素
    • 司机
    • 抑制因素
  • 全球类器官和球状体总潜在市场（TAM）

9. 类器官和球状体市场细分

  • 全球类器官与球状体市场：依类型、表现及预测划分，2019-2024年、2029年预测、2034年预测
  • 全球类器官与球状体市场：依方法、表现及预测划分，2019-2024年、2029年预测、2034年预测
  • 全球类器官和球状体市场：按应用、性能和预测划分，2019-2024年、2029年预测、2034年预测
  • 全球类器官与球状体市场：依最终使用者、表现及预测划分，2019-2024年、2029年预测、2034年预测
  • 全球类器官和球状体市场：按类器官、类型、表现和预测细分，2019-2024年、2029年预测、2034年预测
  • 全球类器官与球状体市场：依球状体类型、表现及预测细分，2019-2024年、2029年预测、2034年预测

第十章 类器官和球状体市场：区域和国家分析

  • 类器官及球状体市场：区域表现及预测，2019-2024年、2029年预测、2034年预测
  • 类器官与球状体市场：国家、表现与预测，2019-2024年、2029年预测、2034年预测

第十一章 亚太市场

第十二章 西欧市场

第十三章 东欧市场

第十四章 北美市场

第十五章：南美市场

第十六章 中东市场

第十七章：非洲市场

第十八章：竞争格局与公司概况

  • 公司简介
  • Thermo Fisher Scientific Inc
  • Corning Inc
  • Merck KGaA（Hubrecht Organoid Technology（HUB））
  • Lonza Group AG
  • STEMCELL Technologies Inc

第十九章：其他领先和创新企业

  • Molecular Devices LLC
  • Cellink（BICO Group）
  • American Type Culture Collection（ATCC）
  • BioIVT
  • InSphero AG
  • Cellesce Ltd.
  • Crown Bioscience Inc.
  • 3D Biomatrix Inc.
  • Mimetas BV
  • 3D Biotek LLC
  • AxoSim Technologies
  • DefiniGEN Limited
  • Prellis Biologics Inc.
  • Revivocell Ltd.
  • Visikol Inc.

第二十章：竞争标竿分析

第21章 竞争格局分析

第22章 重大併购

  • Merck Group Strengthens Next-Generation Biology Capabilities Through Hub Organoids Acquisition

第23章 近期趋势

  • 标准化类器官模型建构倡议：推进人工智慧驱动的药物发现并减少动物试验
  • 引进先进的3D灌注培养系统，以提高精准医疗和药物筛检效率
  • 石墨烯基光刺激技术的突破加速了脑类器官的发育与神经生物混合研究
  • 先进的基于3D类器官的药物筛检平台增强精准医疗并加速药物研发

第24章：机会与策略

  • 2029年类器官和球状体市场－最具新兴机会的国家
  • 2029年类器官和球状体市场－最具新兴机会的细分市场
  • 类器官与球状体市场成长策略展望至2029年
    • 基于市场趋势的策略
    • 竞争对手策略

第25章 类器官和球状体市场：结论与建议

  • 结论
  • 建议

第26章附录

简介目录
Product Code: HS4MOSPH01_O25Q4

Organoids and spheroids refer to three-dimensional (3D) cell culture models developed to closely mimic the architecture, function, and microenvironment of human tissues and organs in vitro. Spheroids are simple, spherical clusters of cells that self-assemble and replicate basic tissue organization, while organoids are more complex, stem cell-derived 3D structures that recreate specific organ functions and cellular diversity. These models are derived from stem cells, primary tissues, or cancer cells and are cultivated in a controlled environment that allows them to self-organize into complex tissue-like structures.

The global organoids and spheroids market reached a value of nearly $1,159.46 million in 2024, having grown at a compound annual growth rate (CAGR) of 20.38% since 2019. The market is expected to grow from $1,159.46 million in 2024 to $2,867.20 million in 2029 at a rate of 19.85%. The market is then expected to grow at a CAGR of 19.34% from 2029 and reach $6,939.47 million in 2034.

Rising Demand For Personalized And Precision Medicine

The rising demand for personalized and precision medicine supported the growth of the organoids and spheroids market in the historic period. These three-dimensional cell culture models closely replicate human tissue architecture and function, enabling more accurate disease modeling, drug screening, and therapeutic testing tailored to individual patients. Pharmaceutical and biotechnology companies increasingly adopted organoids and spheroids to develop targeted treatments, reduce clinical trial failures, and accelerate research and development timelines. The growing focus on patient-specific therapies and customized healthcare solutions fueled the adoption of these advanced models, positioning them as essential tools in precision medicine and contributing to the market's robust expansion. For instance, in February 2024, according to the Personalized Medicine Coalition, a US-based non-profit organization, the United States Food and Drug Administration granted approval for 16 personalized therapies in 2023 aimed at treating rare diseases, marking a rise from the six such treatments approved in 2022. Therefore, the rising demand for personalized and precision medicine drove the growth of the organoids and spheroids market.

Innovative Oxygen-Permeable Culture Technology Enhances 3D Cell Growth And In Vitro Modeling Efficiency

Major companies operating in the organoids and spheroids market are focusing on developing advanced culture platforms and materials that enhance cell viability and oxygen delivery to improve the accuracy and scalability of in vitro models for drug discovery, regenerative medicine, and personalized therapy applications. For instance, in June 2025, Mitsui Chemicals Group, a Japan-based chemical manufacturing company, has introduced its InnoCell oxygen-permeable cell culture microplates. These novel microplates combine the company's specialized materials and precision cutting techniques to enhance oxygen delivery to cells, especially useful in 3D spheroid and organoid cultures, reducing cell death and improving long-term viability. They come in both non-treated (N-type) and collagen-coated (C-type) versions for diverse cell types. The plates also feature low drug adsorption and excellent fluorescence imaging properties. With these advancements, the product is positioned to support drug discovery, personalized medicine, regenerative therapies, and advanced in vitro modeling in pharmaceutical research.

The global organoids and spheroids market is fairly concentrated, with large players operating in the market. The top ten competitors in the market made up to 31.03% of the total market in 2024.

Organoids And Spheroids Global Market Opportunities And Strategies To 2034 from The Business Research Company provides the strategists; marketers and senior management with the critical information they need to assess the global organoids and spheroids market as it emerges from the COVID-19 shut down.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis.

Where is the largest and fastest-growing market for organoids and spheroids? How does the market relate to the overall economy; demography and other similar markets? What forces will shape the market going forward? The organoids and spheroids market global report from The Business Research Company answers all these questions and many more.

The report covers market characteristics; size and growth; segmentation; regional and country breakdowns; competitive landscape; market shares; trends and strategies for this market. It traces the market's history and forecasts market growth by geography. It places the market within the context of the wider organoids and spheroids market; and compares it with other markets.

The report covers the following chapters

  • Introduction and Market Characteristics- Brief introduction to the segmentations covered in the market, definitions and explanations about the segment by type, by method, by application and by end user.
  • Key Trends- Highlights the major trends shaping the global market. This section also highlights likely future developments in the market.
  • Growth Analysis And Strategic Analysis Framework Analysis on PESTEL, end use industries, market growth rate, global historic (2019-2024) and forecast (2024-2029, 2034F) market values and drivers and restraints that support and control the growth of the market in the historic and forecast periods, forecast growth contributors and total addressable market (TAM).
  • Regional And Country Analysis- Historic (2019-2024) and forecast (2024-2029, 2034F) market values and growth and market share comparison by region and country.
  • Market Segmentation- Contains the market values (2019-2024) (2024-2029, 2034F) and analysis for each segment by type, by method, by application and by end user in the market. Historic (2019-2024) and forecast (2024-2029) and (2029-2034) market values and growth and market share comparison by region market.
  • Regional Market Size and Growth- Regional market size (2024), historic (2019-2024) and forecast (2024-2029, 2034F) market values and growth and market share comparison of countries within the region. This report includes information on all the regions Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa and major countries within each region.
  • Competitive Landscape- Details on the competitive landscape of the market, estimated market shares and company profiles of the leading players.
  • Other Major And Innovative Companies Details on the company profiles of other major and innovative companies in the market
  • Competitive Benchmarking- Briefs on the financials comparison between major players in the market.
  • Competitive Dashboard- Briefs on competitive dashboard of major players.
  • Recent Developments Information on recent developments in the market covered in the report.
  • Key Mergers and Acquisitions- Information on recent mergers and acquisitions in the market is covered in the report. This section gives key financial details of mergers and acquisitions which have shaped the market in recent years.
  • Market Opportunities And Strategies- Describes market opportunities and strategies based on findings of the research, with information on growth opportunities across countries, segments and strategies to be followed in those markets.
  • Conclusions And Recommendations- This section includes recommendations for organoids and spheroids providers in terms of product/service offerings geographic expansion, marketing strategies and target groups.
  • Appendix- This section includes details on the NAICS codes covered, abbreviations and currencies codes used in this report.

Markets Covered:

  • 1) By Type: Organoids; Spheroids
  • 2) By Method: Extracellular Matrix Scaffold Method; Spinning Bioreactor Method; Hanging Drop Method; Low Adherent Culture Plate Method; Magnetic Levitation Method; Other Methods
  • 3) By Application: Developmental Biology; Personalized Medicine; Regenerative Medicine; Disease Pathology Studies; Drug Toxicity And Efficacy Testing
  • 4) By End-User: Biotechnology And Pharmaceutical Industry; Academic And Research Institutes; Hospitals And Diagnostic Centers
  • Companies Mentioned: Thermo Fisher Scientific Inc.; Corning Incorporated; Merck KGaA (Hubrecht Organoid Technology (HUB)); Lonza Group AG; StemCell Technologies Inc.
  • Countries: China; Australia; India; Indonesia; Japan; South Korea; USA; Canada; Brazil; France; Germany; UK; Italy; Spain; Russia
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time-series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets; GDP proportions; expenditure per capita; organoids and spheroids indicators comparison.
  • Data segmentations: country and regional historic and forecast data; market share of competitors; market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Table of Contents

1 Executive Summary

  • 1.1 Organoids And Spheroids - Market Attractiveness And Macro Economic Landscape

2 Table Of Contents

3 List Of Tables

4 List Of Figures

5 Report Structure

6 Market Characteristics

  • 6.1 General Market Definition
  • 6.2 Summary
  • 6.3 Organoids And Spheroids Market Definition And Segmentations
  • 6.4 Market Segmentation By Type
    • 6.4.1 Organoids
    • 6.4.2 Spheroids
  • 6.5 Market Segmentation By Method
    • 6.5.1 Extracellular Matrix Scaffold Method
    • 6.5.2 Spinning Bioreactor Method
    • 6.5.3 Hanging Drop Method
    • 6.5.4 Low Adherent Culture Plate Method
    • 6.5.5 Magnetic Levitation Method
    • 6.5.6 Other Methods
  • 6.6 Market Segmentation By Application
    • 6.6.1 Developmental Biology
    • 6.6.2 Personalized Medicine
    • 6.6.3 Regenerative Medicine
    • 6.6.4 Disease Pathology Studies
    • 6.6.5 Drug Toxicity and Efficacy Testing
  • 6.7 Market Segmentation By End-User
    • 6.7.1 Biotechnology and Pharmaceutical Industry
    • 6.7.2 Academic and Research Institutes
    • 6.7.3 Hospitals and Diagnostic Centers

7 Major Market Trends

  • 7.1 Innovative Oxygen-Permeable Culture Technology Enhances 3D Cell Growth And In Vitro Modeling Efficiency
  • 7.2 Vascularized Organoid Engineering Opens New Pathways For Regenerative Medicine And Disease Modeling
  • 7.3 Scalable Functional Liver Organoid Breakthrough Advances Regenerative Medicine And Drug Testing Applications
  • 7.4 AI-Integrated Cardiac Organoid Innovation Enhances Drug Safety And Precision Medicine
  • 7.5 Integrated 3D Cell Culture Technologies Accelerate Advances In Regenerative Medicine And Biopharma Research

8 Organoids And Spheroids Growth Analysis And Strategic Analysis Framework

  • 8.1 Global Organoids And Spheroids PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
    • 8.1.1 Political
    • 8.1.2 Economic
    • 8.1.3 Social
    • 8.1.4 Technological
    • 8.1.5 Environmental
    • 8.1.6 Legal
  • 8.2 Analysis Of End User (B2B) Market
    • 8.2.1 Biotechnology And Pharmaceutical Industry
    • 8.2.2 Academic And Research Institutes
    • 8.2.3 Hospitals And Diagnostic Centers
  • 8.3 Organoids And Spheroids Market Growth Rate Analysis
  • 8.4 Global Historic Market Growth, 2019 - 2024, Value ($ Million)
    • 8.4.1 Market Drivers 2019 - 2024
    • 8.4.2 Market Restraints 2019 - 2024
  • 8.5 Global Forecast Market Growth, 2024 - 2029, 2034F Value ($ Million)
  • 8.6 Forecast Growth Contributors/Factors
    • 8.6.1 Quantitative Growth Contributors
    • 8.6.2 Drivers
    • 8.6.3 Restraints
  • 8.7 Global Organoids And Spheroids Total Addressable Market (TAM)

9 Organoids And Spheroids Market Segmentation

  • 9.1 Global Organoids And Spheroids Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 9.2 Global Organoids And Spheroids Market, Segmentation By Method, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 9.3 Global Organoids And Spheroids Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 9.4 Global Organoids And Spheroids Market, Segmentation By End-User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 9.5 Global Organoids And Spheroids Market, Sub-Segmentation Of Organoids, By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 9.6 Global Organoids And Spheroids Market, Sub-Segmentation Of Spheroids, By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)

10 Organoids And Spheroids Market, Regional and Country Analysis

  • 10.1 Organoids And Spheroids Market, By Region, Historic and Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 10.2 Organoids And Spheroids Market, By Country, Historic and Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)

11 Asia-Pacific Market

  • 11.1 Summary
  • 11.2 Market Overview
    • 11.2.1 Region Information
    • 11.2.2 Market Information
    • 11.2.3 Background Information
    • 11.2.4 Government Initiatives
    • 11.2.5 Regulations
    • 11.2.6 Regulatory Bodies
    • 11.2.7 Major Associations
    • 11.2.8 Taxes Levied
    • 11.2.9 Corporate Tax Structure
    • 11.2.10 Investments
    • 11.2.11 Major Companies
  • 11.3 Asia-Pacific Organoids And Spheroids Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 11.4 Asia-Pacific Organoids And Spheroids Market, Segmentation By Method, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 11.5 Asia-Pacific Organoids And Spheroids Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 11.6 China Market
  • 11.7 Summary
  • 11.8 Market Overview
    • 11.8.1 Country Information
    • 11.8.2 Market Information
    • 11.8.3 Background Information
    • 11.8.4 Government Initiatives
    • 11.8.5 Regulations
    • 11.8.6 Regulatory Bodies
    • 11.8.7 Major Associations
    • 11.8.8 Taxes Levied
    • 11.8.9 Corporate Tax Structure
    • 11.8.10 Investments
    • 11.8.11 Major Companies
  • 11.9 China Organoids And Spheroids Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 11.10 China Organoids And Spheroids Market, Segmentation By Method, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 11.11 China Organoids And Spheroids Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 11.12 India Market
  • 11.13 India Organoids And Spheroids Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 11.14 India Organoids And Spheroids Market, Segmentation By Method, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 11.15 India Organoids And Spheroids Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 11.16 Japan Market
  • 11.17 Summary
  • 11.18 Market Overview
    • 11.18.1 Country Information
    • 11.18.2 Market Information
    • 11.18.3 Background Information
    • 11.18.4 Government Initiatives
    • 11.18.5 Regulations
    • 11.18.6 Regulatory Bodies
    • 11.18.7 Major Associations
    • 11.18.8 Taxes Levied
    • 11.18.9 Corporate Tax Structure
    • 11.18.10 Investments
    • 11.18.11 Major Companies
  • 11.19 Japan Organoids And Spheroids Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 11.20 Japan Organoids And Spheroids Market, Segmentation By Method, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 11.21 Japan Organoids And Spheroids Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 11.22 Australia Market
  • 11.23 Australia Organoids And Spheroids Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 11.24 Australia Organoids And Spheroids Market, Segmentation By Method, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 11.25 Australia Organoids And Spheroids Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 11.26 Indonesia Market
  • 11.27 Indonesia Organoids And Spheroids Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 11.28 Indonesia Organoids And Spheroids Market, Segmentation By Method, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 11.29 Indonesia Organoids And Spheroids Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 11.30 South Korea Market
  • 11.31 Summary
  • 11.32 Market Overview
    • 11.32.1 Country Information
    • 11.32.2 Market Information
    • 11.32.3 Background Information
    • 11.32.4 Government Initiatives
    • 11.32.5 Regulations
    • 11.32.6 Regulatory Bodies
    • 11.32.7 Major Associations
    • 11.32.8 Taxes Levied
    • 11.32.9 Corporate Tax Structure
    • 11.32.10 Investments
    • 11.32.11 Major Companies
  • 11.33 South Korea Organoids And Spheroids Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 11.34 South Korea Organoids And Spheroids Market, Segmentation By Method, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 11.35 South Korea Organoids And Spheroids Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)

12 Western Europe Market

  • 12.1 Summary
  • 12.2 Market Overview
    • 12.2.1 Region Information
    • 12.2.2 Market Information
    • 12.2.3 Background Information
    • 12.2.4 Government Initiatives
    • 12.2.5 Regulations
    • 12.2.6 Regulatory Bodies
    • 12.2.7 Major Associations
    • 12.2.8 Taxes Levied
    • 12.2.9 Corporate tax structure
    • 12.2.10 Investments
    • 12.2.11 Major Companies
  • 12.3 Western Europe Organoids And Spheroids Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 12.4 Western Europe Organoids And Spheroids Market, Segmentation By Method, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 12.5 Western Europe Organoids And Spheroids Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 12.6 Western Europe Organoids And Spheroids Market: Country Analysis
  • 12.7 UK Market
  • 12.8 UK Organoids And Spheroids Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 12.9 UK Organoids And Spheroids Market, Segmentation By Method, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 12.10 UK Organoids And Spheroids Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 12.11 Germany Market
  • 12.12 Germany Organoids And Spheroids Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 12.13 Germany Organoids And Spheroids Market, Segmentation By Method, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 12.14 Germany Organoids And Spheroids Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 12.15 France Market
  • 12.16 France Organoids And Spheroids Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 12.17 France Organoids And Spheroids Market, Segmentation By Method, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 12.18 France Organoids And Spheroids Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 12.19 Italy Market
  • 12.20 Italy Organoids And Spheroids Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 12.21 Italy Organoids And Spheroids Market, Segmentation By Method, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 12.22 Italy Organoids And Spheroids Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 12.23 Spain Market
  • 12.24 Spain Organoids And Spheroids Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 12.25 Spain Organoids And Spheroids Market, Segmentation By Method, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 12.26 Spain Organoids And Spheroids Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)

13 Eastern Europe Market

  • 13.1 Summary
  • 13.2 Market Overview
    • 13.2.1 Region Information
    • 13.2.2 Market Information
    • 13.2.3 Background Information
    • 13.2.4 Government Initiatives
    • 13.2.5 Regulations
    • 13.2.6 Regulatory Bodies
    • 13.2.7 Major Associations
    • 13.2.8 Taxes Levied
    • 13.2.9 Corporate Tax Structure
    • 13.2.10 Major companies
  • 13.3 Eastern Europe Organoids And Spheroids Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 13.4 Eastern Europe Organoids And Spheroids Market, Segmentation By Method, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 13.5 Eastern Europe Organoids And Spheroids Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 13.6 Eastern Europe Organoids And Spheroids Market: Country Analysis
  • 13.7 Russia Market
  • 13.8 Russia Organoids And Spheroids Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 13.9 Russia Organoids And Spheroids Market, Segmentation By Method, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 13.10 Russia Organoids And Spheroids Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)

14 North America Market

  • 14.1 Summary
  • 14.2 Market Overview
    • 14.2.1 Region Information
    • 14.2.2 Market Information
    • 14.2.3 Background Information
    • 14.2.4 Government Initiatives
    • 14.2.5 Regulations
    • 14.2.6 Regulatory Bodies
    • 14.2.7 Major Associations
    • 14.2.8 Taxes Levied
    • 14.2.9 Corporate Tax Structure
    • 14.2.10 Investments
    • 14.2.11 Major Companies
  • 14.3 North America Organoids And Spheroids Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 14.4 North America Organoids And Spheroids Market, Segmentation By Method, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 14.5 North America Organoids And Spheroids Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 14.6 North America Organoids And Spheroids Market: Country Analysis
  • 14.7 USA Market
  • 14.8 Summary
  • 14.9 Market Overview
    • 14.9.1 Country Information
    • 14.9.2 Market Information
    • 14.9.3 Background Information
    • 14.9.4 Government Initiatives
    • 14.9.5 Regulations
    • 14.9.6 Regulatory Bodies
    • 14.9.7 Major Associations
    • 14.9.8 Taxes Levied
    • 14.9.9 Corporate Tax Structure
    • 14.9.10 Investments
    • 14.9.11 Major Companies
  • 14.10 USA Organoids And Spheroids Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 14.11 USA Organoids And Spheroids Market, Segmentation By Method, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 14.12 USA Organoids And Spheroids Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 14.13 Canada Market
  • 14.14 Summary
  • 14.15 Market Overview
    • 14.15.1 Country Information
    • 14.15.2 Market Information
    • 14.15.3 Background Information
    • 14.15.4 Government Initiatives
    • 14.15.5 Regulations
    • 14.15.6 Regulatory Bodies
    • 14.15.7 Major Associations
    • 14.15.8 Taxes Levied
    • 14.15.9 Corporate Tax Structure
    • 14.15.10 Major Companies
  • 14.16 Canada Organoids And Spheroids Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 14.17 Canada Organoids And Spheroids Market, Segmentation By Method, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 14.18 Canada Organoids And Spheroids Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)

15 South America Market

  • 15.1 Summary
  • 15.2 Market Overview
    • 15.2.1 Region Information
    • 15.2.2 Market Information
    • 15.2.3 Background Information
    • 15.2.4 Government Initiatives
    • 15.2.5 Regulations
    • 15.2.6 Regulatory Bodies
    • 15.2.7 Major Associations
    • 15.2.8 Taxes Levied
    • 15.2.9 Corporate Tax Structure
    • 15.2.10 Major Companies
  • 15.3 South America Organoids And Spheroids Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 15.4 South America Organoids And Spheroids Market, Segmentation By Method, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 15.5 South America Organoids And Spheroids Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 15.6 South America Organoids And Spheroids Market: Country Analysis
  • 15.7 Brazil Market
  • 15.8 Brazil Organoids And Spheroids Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 15.9 Brazil Organoids And Spheroids Market, Segmentation By Method, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 15.10 Brazil Organoids And Spheroids Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)

16 Middle East Market

  • 16.1 Summary
  • 16.2 Market Overview
    • 16.2.1 Region Information
    • 16.2.2 Market Information
    • 16.2.3 Background Information
    • 16.2.4 Government Initiatives
    • 16.2.5 Regulations
    • 16.2.6 Regulatory Bodies
    • 16.2.7 Major Associations
    • 16.2.8 Taxes Levied
    • 16.2.9 Corporate Tax Structure
    • 16.2.10 Investments
    • 16.2.11 Major Companies
  • 16.3 Middle East Organoids And Spheroids Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 16.4 Middle East Organoids And Spheroids Market, Segmentation By Method, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 16.5 Middle East Organoids And Spheroids Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)

17 Africa Market

  • 17.1 Summary
  • 17.2 Market Overview
    • 17.2.1 Region Information
    • 17.2.2 Market Information
    • 17.2.3 Background Information
    • 17.2.4 Government Initiatives
    • 17.2.5 Regulations
    • 17.2.6 Regulatory Bodies
    • 17.2.7 Major Associations
    • 17.2.8 Taxes Levied
    • 17.2.9 Corporate Tax Structure
    • 17.2.10 Investments
    • 17.2.11 Major Companies
  • 17.3 Africa Organoids And Spheroids Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 17.4 Africa Organoids And Spheroids Market, Segmentation By Method, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 17.5 Africa Organoids And Spheroids Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)

18 Competitive Landscape And Company Profiles

  • 18.1 Company Profiles
  • 18.2 Thermo Fisher Scientific Inc
    • 18.2.1 Company Overview
    • 18.2.2 Products And Services
    • 18.2.3 Business Strategy
    • 18.2.4 Financial Overview
  • 18.3 Corning Inc
    • 18.3.1 Company Overview
    • 18.3.2 Products And Services
    • 18.3.3 Business Strategy
    • 18.3.4 Financial Overview
  • 18.4 Merck KGaA (Hubrecht Organoid Technology (HUB))
    • 18.4.1 Company Overview
    • 18.4.2 Products And Services
    • 18.4.3 Financial Overview
  • 18.5 Lonza Group AG
    • 18.5.1 Company Overview
    • 18.5.2 Products And Services
    • 18.5.3 Business Strategy
    • 18.5.4 Financial Overview
  • 18.6 STEMCELL Technologies Inc
    • 18.6.1 Company Overview
    • 18.6.2 Products And Services
    • 18.6.3 Business Strategy
    • 18.6.4 Financial Overview

19 Other Major And Innovative Companies

  • 19.1 Molecular Devices LLC
    • 19.1.1 Company Overview
    • 19.1.2 Products And Services
  • 19.2 Cellink (BICO Group)
    • 19.2.1 Company Overview
    • 19.2.2 Products And Services
  • 19.3 American Type Culture Collection (ATCC)
    • 19.3.1 Company Overview
    • 19.3.2 Products And Services
  • 19.4 BioIVT
    • 19.4.1 Company Overview
    • 19.4.2 Products And Services
  • 19.5 InSphero AG
    • 19.5.1 Company Overview
    • 19.5.2 Products And Services
  • 19.6 Cellesce Ltd.
    • 19.6.1 Company Overview
    • 19.6.2 Products And Services
  • 19.7 Crown Bioscience Inc.
    • 19.7.1 Company Overview
    • 19.7.2 Products And Services
  • 19.8 3D Biomatrix Inc.
    • 19.8.1 Company Overview
    • 19.8.2 Products And Services
  • 19.9 Mimetas B.V.
    • 19.9.1 Company Overview
    • 19.9.2 Products And Services
  • 19.10 3D Biotek LLC
    • 19.10.1 Company Overview
    • 19.10.2 Products And Services
  • 19.11 AxoSim Technologies
    • 19.11.1 Company Overview
    • 19.11.2 Products And Services
  • 19.12 DefiniGEN Limited
    • 19.12.1 Company Overview
    • 19.12.2 Products And Services
  • 19.13 Prellis Biologics Inc.
    • 19.13.1 Company Overview
    • 19.13.2 Products And Services
  • 19.14 Revivocell Ltd.
    • 19.14.1 Company Overview
    • 19.14.2 Products And Services
  • 19.15 Visikol Inc.
    • 19.15.1 Company Overview
    • 19.15.2 Products And Services

20 Competitive Benchmarking

21 Competitive Dashboard

22 Key Mergers And Acquisitions

  • 22.1 Merck Group Strengthens Next-Generation Biology Capabilities Through Hub Organoids Acquisition

23 Recent Development

  • 23.1 Standardized Organoid Modeling Initiative To Advance AI-Driven Drug Discovery And Reduce Animal Testing
  • 23.2 Advanced 3D Perfusion Culture System Introduced To Enhance Precision Medicine And Drug Screening Efficiency
  • 23.3 Graphene-Based Optical Stimulation Breakthrough Accelerates Brain Organoid Development And Neuro-Biohybrid Research
  • 23.4 Advanced 3D Organoid-Based Drug Screening Platform Enhances Precision Medicine And Accelerates Drug Development

24 Opportunities And Strategies

  • 24.1 Organoids And Spheroids Market In 2029 - Countries Offering Most New Opportunities
  • 24.2 Organoids And Spheroids Market In 2029 - Segments Offering Most New Opportunities
  • 24.3 Organoids And Spheroids Market In 2029 - Growth Strategies
    • 24.3.1 Market Trend Based Strategies
    • 24.3.2 Competitor Strategies

25 Organoids And Spheroids Market, Conclusions And Recommendations

  • 25.1 Conclusions
  • 25.2 Recommendations
    • 25.2.1 Product
    • 25.2.2 Place
    • 25.2.3 Price
    • 25.2.4 Promotion
    • 25.2.5 People

26 Appendix

  • 26.1 Geographies Covered
  • 26.2 Market Data Sources
  • 26.3 Research Methodology
  • 26.4 Currencies
  • 26.5 The Business Research Company
  • 26.6 Copyright and Disclaimer